Epalinges
Switzerland
9
2025-10-23
4
2025-08-05
These are the the leading inventors for applications assigned to Gnubiotics Sciences SA:
Gnubiotics Sciences SA based in Epalinges, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
GLYCOPEPTIDE MEDIATED T CELL IMMUNITY AND ANTI-TUMOR EFFICACY IN CANCER
#2 | 2025-10-02MICROBIOME BIOMARKERS FOR IRRITABLE BOWEL DISEASE (IBD)
#3 | 2025-09-18GLYCAN PROGRAMMED CELL THERAPY
#4 | 2025-07-24PROCESS OF PREPARATION OF GLYCAN COMPOSITIONS & USES THEREOF
#5 | 2025-03-13COMPOSITIONS FROM GASTROINTESTINAL TRACT MUCINS, AND USES THEREOF
#6 | 2023-12-07 โ Patent 12,378,611 granted on 2025-08-05MICROBIOME MARKERS AND USES THEREOF
#7 | 2022-08-04 โ Patent 12,037,651 granted on 2024-07-16Microbiome markers and uses thereof
#8 | 2021-09-09 โ Patent 11,229,671 granted on 2022-01-25Microbiome markers and uses thereof
#9 | 2020-12-24 โ Patent 12,144,842 granted on 2024-11-19Process of preparation of glycan compositions and uses thereof
Also check out Gnubiotics Sciences SA's (Epalinges, Switzerland) applicant profile with 7 patent applications submitted.
370768 โ